Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients-Reference-Cited by-同舟云学术

Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients

Published:2022-08-04 Issue:10 Volume:106 Page:e463-e464
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Shertel Tara,Lange Nicholas W.,Salerno David M.,Hedvat Jessica,Jennings Douglas L.,Choe Jason Y.,Brown Robert S.,Pereira Marcus R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference5 articles.

1. COVID-19 in solid organ transplant recipients: initial report from the US epicenter.;Pereira;Am J Transplant,2020

2. Early clinical experience with nirmatrelvir/ritonavir for the treatment of COVID-19 in solid organ transplant recipients.;Salerno;Am J Transplant,2022

3. Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge.;Radcliffe;Am J Transplant,2022

4. Efficacy of antiviral agents against the SARS-CoV-2 Omicron subvariant BA.2.;Takashita;N Engl J Med,2022

5. Neutralization sensitivity of SARS-CoV-2 Omicron subvariants to therapeutic monoclonal antibodies.;Yamasoba;Lancet Infect Dis,2022

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer center;Transplant Infectious Disease;2024-01-08

2. Update of the recommendations on the management of the SARS-CoV-2 coronavirus pandemic (COVID-19) in kidney transplant patients;Nefrología (English Edition);2023-09

3. SARS-CoV-2 neutralizing antibody bebtelovimab – a systematic scoping review and meta-analysis;Frontiers in Immunology;2023-08-28

4. Safety, Tolerability, Bioavailability, and Biological Activity of Inhaled Interferon-α2b in Healthy Adults: The IN2COVID Phase I Randomized Trial;Clinical Drug Investigation;2023-06

5. Outcomes of Bebtelovimab Therapy in Patients With Solid Organ Transplantation With Mild and Moderate COVID-19;Cureus;2023-05-11